TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $47.16M2017: $89.91M2018: $74.91M2019: $219.75M2020: $492.85M2021: $844.29M2022: $1.04B2023: $1.83B2024: $2.25B2025: $3.71B$3.71B
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$3.71B+65.2%
2024$2.25B+23.0%
2023$1.83B+76.2%
2022$1.04B+22.9%
2021$844.29M+71.3%
2020$492.85M+124.3%
2019$219.75M+193.4%
2018$74.91M-16.7%
2017$89.91M+90.7%
2016$47.16M—